Genetics May Explain Variable Results of Weight-Loss Injections
Scientists have identified genetic variations that may explain why weight-loss injections, specifically GLP1 receptor agonists like Wegovy and Mounjaro, yield different results among patients. A study analyzing data from nearly 28,000 individuals found that specific gene variants influence both the efficacy of weight loss and the likelihood of side effects such as nausea. While these findings offer a potential pathway for personalized obesity treatments, experts caution that the genetic impact is modest compared to non-genetic factors like dosage, drug type, and behavioral changes. Consequently, while the research supports future precision medicine approaches, it does not yet provide sufficient evidence to guide routine clinical decisions based solely on genetics.
Wire timeline
Genetics May Explain Variable Results of Weight-Loss Injections
Scientists have identified genetic variations that may explain why weight-loss injections, specifically GLP1 receptor agonists like Wegovy and Mounjaro, yield different results among patients. A study analyzing data from nearly 28,000 individuals found that specific gene variants influence both the efficacy of weight loss and the likelihood of side effects such as nausea. While these findings offer a potential pathway for personalized obesity treatments, experts caution that the genetic impact is modest compared to non-genetic factors like dosage, drug type, and behavioral changes. Consequently, while the research supports future precision medicine approaches, it does not yet provide sufficient evidence to guide routine clinical decisions based solely on genetics.
The Guardian